Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 5;25(8):1897–1906. doi: 10.1177/1078155219827637

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Sample attribution flow chart for patients with hematologic malignancy. Hematologic malignancy includes chronic myeloid leukemia, chronic lymphocytic leukemia, mantle cell lymphoma, acute myeloid leukemia, acute lymphocytic leukemia, myeloproliferative neoplasms, follicular lymphoma, marginal zone lymphoma, Waldenström's macroglobulinemia, and multiple myeloma.

ICD-9/10 CM: International Classification of Diseases, Ninth Revision, Clinical Modification.

^aIndex date represents the date of first oral oncolytic treatment observed between 1 January 2011 and 30 September 2016, inclusive. Patients with any other solid tumor are not excluded from the analysis.